Latest Liquidity News

Vulcan Energy Resources reported a robust cash position of €97 million at the end of 2024 despite significant cash outflows driven by exploration and development activities. The company’s strong liquidity is supported by unused financing facilities, positioning it well for upcoming operational demands.

Centrex Limited stabilises operations at Ardmore Mine, completes Australia’s first phosphate export to India, and launches a $10.4 million entitlement offer to fund expansion.

Emerald Resources NL has reported record quarterly gold production at its Okvau Gold Mine, alongside significant resource expansions in Cambodia and Australia, positioning the company for robust growth.

Fluence Corporation Limited reported a net cash outflow of US$3.03 million for the December 2024 quarter, maintaining liquidity with nearly US$9 million in cash and expanded credit facilities.

Percheron Therapeutics has terminated its phase IIb avicursen trial for Duchenne muscular dystrophy after failing to meet efficacy endpoints, while securing $14.85 million in fresh capital to explore new therapeutic opportunities.

Australian Dairy Nutritionals Limited reports improved cash flow in Q2 FY25 and prepares for the strategic launch of its premium Future brand in China, aiming to reshape its growth trajectory.

Pro-Pac Packaging reported a revenue increase to $73.1 million for Q2 FY25, supported by new financing facilities and a fresh CEO appointment, while navigating cash flow pressures and challenging market conditions.

Norwood Systems has secured a fifth variation to its cash drawdown facility, increasing the principal to $720,114 and extending repayment to mid-February 2025. The move underscores ongoing financial support from a key director amid evolving capital needs.

Immutep Limited has initiated its pivotal Phase III trial for eftilagimod alfa in first-line non-small cell lung cancer, supported by compelling survival outcomes from ongoing studies and a robust cash position expected to fund operations through 2026.

Axiom Properties Limited reported a $518,000 increase in cash reserves for the December quarter, reaching $1.86 million, while extending key debt facilities to support its Mt Barker development and the rapidly expanding ListSure business.

Brookside Energy Ltd delivered a standout quarter in Q4 2024, posting record production growth and a 667% jump in operating cash flow, while completing a major development project ahead of schedule and under budget.

Vitrafy Life Sciences reports strong Q2 FY2025 progress, marked by a successful $35 million IPO, promising validation results in animal and human health, and strategic expansion into North America.